Mereo BioPharma Group plc (MREO) NASDAQ
0.34
+0.0316(+10.27%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 66.43M |
| Enterprise Value | 25.64M |
| P/E Ratio | -1.37 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 97.65 |
| Price/Book Ratio | 1.44 |
| Enterprise/Revenue | 24.99 |
| Enterprise/EBITDA | -0.32 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -71.4 |
| Operating Margin | -75.31 |
Management Effectiveness
| Return On Assets | -0.88 |
| Return On Equity | -0.81 |
Income Statement
| Revenue | 500,000 |
| Revenue/Share | 0 |
| Gross Profit | 367,000 |
| EBITDA | -40.47M |
| Net Income | -41.88M |
| Diluted EPS | -0.26 |
Balance Sheet
| Total Cash | 36.22M |
| Total Cash/Share | 0.23 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.48 |
| Book Value Per Share | 0.21 |
Price History
| 52-Week Change | -88.03 |
| 52-Week High | 3.05 |
| 52-Week Low | 0.2 |
| Moving Average 50 Days | 0.3 |
| Moving Average 200 Days | 1.09 |
Statistics
| Average Volume | 3M |
| Shares Outstanding | 159.62M |
| % Held by Institutions | 47.28 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
